These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 10080425)

  • 21. Effects of enalapril on left ventricular mass and diastolic function in essential hypertension: special reference to duration of hypertension.
    Oki T; Fukuda N; Iuchi A; Tabata T; Sasaki M; Kawahara K; Ishimoto T; Tominaga T; Okushi H; Fujimoto T; Ito S
    J Card Fail; 1995 Dec; 1(5):365-70. PubMed ID: 12836711
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
    Palmieri V; Devereux RB
    Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of enalapril versus nifedipine to decrease left ventricular hypertrophy in systemic hypertension (the PRESERVE trial).
    Devereux RB; Dahlof B; Levy D; Pfeffer MA
    Am J Cardiol; 1996 Jul; 78(1):61-5. PubMed ID: 8712120
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of spirapril, isradipine, or combination in hypertensive patients with left ventricular hypertrophy: effects on LVH regression and arrhythmogenic propensity.
    Manolis AJ; Beldekos D; Handanis S; Haralabidis G; Hatzissavas J; Foussas S; Cokkinos DV; Bresnahan M; Gavras I; Gavras H
    Am J Hypertens; 1998 Jun; 11(6 Pt 1):640-8. PubMed ID: 9657622
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects on left ventricular mass and function of low doses of enalapril for systemic hypertension.
    González-Juanatey JR; Reino AP; García-Acuña JM; Varela Román A; Calvo Gómez C; Cabezas-Cerrato J
    Am J Cardiol; 1998 Jan; 81(1):87-90. PubMed ID: 9462614
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effects of verapamil on left ventricular mass and diastolic function in hypertensive patients].
    Sau F; Seguro C; Alvau MD; Pargentino E; Cherchi A
    Cardiologia; 1993 Nov; 38(11):727-32. PubMed ID: 8004645
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronic enalapril treatment increases transient outward potassium current in cardiomyocytes isolated from right ventricle of spontaneously hypertensive rats.
    Rodrigues Junior LF; de Azevedo Carvalho AC; Pimentel EB; Mill JG; Nascimento JH
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Mar; 390(3):225-234. PubMed ID: 27915452
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regression of left ventricular hypertrophy in hypertensive heart transplant recipients treated with enalapril, furosemide, and verapamil.
    Angermann CE; Spes CH; Willems S; Dominiak P; Kemkes BM; Theisen K
    Circulation; 1991 Aug; 84(2):583-93. PubMed ID: 1830519
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enalapril influence on blood pressure and echocardiographic parameters in children with acute postinfectious glomerulonephritis.
    Jankauskiene A; Cerniauskiene V; Jakutovic M; Malikenas A
    Medicina (Kaunas); 2005; 41(12):1019-25. PubMed ID: 16401958
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Left ventricular (LV) geometry and dipping state are determinants of LV mass reduction with angiotensin-converting enzyme inhibitor antihypertensive treatment.
    Aznaouridis KA; Vyssoulis GP; Karpanou EA; Marinakis AG; Barbetseas JD; Zervoudaki AI; Cokkinos DV; Stefanadis CI
    Blood Press Monit; 2007 Apr; 12(2):87-94. PubMed ID: 17353651
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect of enalapril on left ventricular hypertrophy and left ventricular function in patients with hypertension].
    Kakinoki S; Takechi S; Hashimoto M; Sakuma I; Nomura A; Kitabatake A; Yasuda H
    Kokyu To Junkan; 1993 Dec; 41(12):1185-9. PubMed ID: 8284542
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of the effects of isradipine and lisinopril on left ventricular structure and function in essential hypertension.
    Bielen EC; Fagard RH; Lijnen PJ; Tjandra-Maga TB; Verbesselt R; Amery AK
    Am J Cardiol; 1992 May; 69(14):1200-6. PubMed ID: 1315483
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison study of the echocardiographic changes in hypertensive patients treated with telmisartan vs. enalapril.
    Hadi NR; Abdulzahra MS; Al-Huseini LM; Al-Aubaidy HA
    Int J Cardiol; 2017 Mar; 230():269-274. PubMed ID: 28041700
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of antihypertensive therapy on left atrial function.
    Dernellis JM; Vyssoulis GP; Zacharoulis AA; Toutouzas PK
    J Hum Hypertens; 1996 Dec; 10(12):789-94. PubMed ID: 9140783
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative effects of chronic ACE inhibition and AT1 receptor blocked losartan on cardiac hypertrophy and renal function in hypertensive patients.
    De Rosa ML; Cardace P; Rossi M; Baiano A; de Cristofaro A
    J Hum Hypertens; 2002 Feb; 16(2):133-40. PubMed ID: 11850771
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evolution of left ventricular hypertrophy and function during long-term treatment of systemic hypertension with enalapril.
    González-Juanatey JR; Pose Reino A; Román AV; García Acuña JM; Fernández López JA; Cerrato JC
    Am J Cardiol; 1997 Feb; 79(3):373-6. PubMed ID: 9036764
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changes in left ventricular geometry during antihypertensive treatment.
    Salvetti M; Paini A; Bertacchini F; Stassaldi D; Aggiusti C; Agabiti Rosei C; Bassetti D; Agabiti-Rosei E; Muiesan ML
    Pharmacol Res; 2018 Aug; 134():193-199. PubMed ID: 29959031
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Regression of hypertensive heart hypertrophy caused by chronic angiotensin-converting enzyme inhibition].
    Motz W; Strauer BE
    Z Kardiol; 1988 Jan; 77(1):53-60. PubMed ID: 2834885
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of the direct Renin inhibitor aliskiren, the Angiotensin receptor blocker losartan, or both on left ventricular mass in patients with hypertension and left ventricular hypertrophy.
    Solomon SD; Appelbaum E; Manning WJ; Verma A; Berglund T; Lukashevich V; Cherif Papst C; Smith BA; Dahlöf B;
    Circulation; 2009 Feb; 119(4):530-7. PubMed ID: 19153265
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of drug therapy on cardiac arrhythmias and ischemia in hypertensives with LVH.
    Novo S; Abrignani MG; Novo G; Nardi E; Dominguez LJ; Strano A; Barbagallo M
    Am J Hypertens; 2001 Jul; 14(7 Pt 1):637-43. PubMed ID: 11465647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.